Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Compass Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Compass Therapeutics Inc
Rating: 0.92058325
Author: Trendlyne DVM scores

about

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

2.02 -0.04 (-1.94%)

70.64% Fall from 52W High

3.1M

XNAS Volume

XNAS 24 Jun, 2026 5:30 PM (EDT)

Not Eligible

Expensive Valuation

10.3 / 100

Technically Bearish

26.5 / 100

1Yr Price target upside is 575%

14 analysts

Compass Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Compass Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Compass Therapeutics Inc is a clinical-stage oncology-focused biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat multiple human diseases. The company's scientific focus is on the relationshi...

70.64% Fall from 52W High

SWOT Analysis

Compass Therapeutics Inc Live Price Chart